Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DCPH
- Price
- -
- Stock movement up
- +0.02 (0.08%)
- Company name
- Deciphera Pharmaceuticals LLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 2.21B
- Ent value
- 2.23B
- Price/Sales
- 12.65
- Price/Book
- 7.00
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -4.07%
- 1 year return
- 83.05%
- 3 year return
- -8.90%
- 5 year return
- 3.14%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
DCPH does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 12.65 |
| Price to Book | 7.00 |
| EV to Sales | 12.73 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 86.48M |
| EPS (TTM) | -2.18 |
| FCF per share (TTM) | -1.74 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 174.91M |
| Gross profit (TTM) | 167.98M |
| Operating income (TTM) | -206.55M |
| Net income (TTM) | -190.42M |
| EPS (TTM) | -2.18 |
| EPS (1y forward) | -1.68 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 96.04% |
| Operating margin (TTM) | -118.09% |
| Profit margin (TTM) | -108.87% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 91.23M |
| Net receivables | 32.68M |
| Total current assets | 349.94M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 36.08M |
| Total assets | 420.93M |
| Accounts payable | 19.46M |
| Short/Current long term debt | 25.02M |
| Total current liabilities | 83.43M |
| Total liabilities | 104.88M |
| Shareholder's equity | 316.05M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -151.83M |
| Capital expenditures (TTM) | 564.00K |
| Free cash flow (TTM) | -152.39M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -60.25% |
| Return on Assets | -45.24% |
| Return on Invested Capital | -59.58% |
| Cash Return on Invested Capital | -47.68% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| DCPH | S&P500 | |
| Current price drop from All-time high | -63.41% | - |
| Highest price drop | -90.18% | -56.47% |
| Date of highest drop | 7 Mar 2022 | 9 Mar 2009 |
| Avg drop from high | -48.80% | -10.99% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 1127 days | 1805 days |
COMPANY DETAILS
Marketcap
2.21B
Marketcap category
Mid-cap
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. As of June 11, 2024, Deciphera Pharmaceuticals, Inc. operates as a subsidiary of Ono Pharmaceutical Co., Ltd.
Employees
355
Website
Investor relations
-
SEC filings
CEO
Steven L. Hoerter
Country
USA
City
Waltham
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner